Arrogene
Company

Last deal

$3.23M

Amount

Venture - Series Unknown

Stage

08.05.2018

Date

3

all rounds

$7.9M

Total amount

date founded

Financing round

General

About Company
Arrogene develops nano-biopolymers and technologies for cancer therapeutics and diagnostics.

Industry

Sector :

Subsector :

Keywords :

Also Known As

ARROGENE NANOTECHNOLOGY INC, SRKP 16 INC

founded date

01.01.2007

Number of employees

Company Type

For Profit

Last funding type

Venture - Series Unknown

IPO status

Private

Description

The company's unique nano-medicine platform delivers multiple tumor inhibitors or imaging agents and is being tailored to fight different types of cancer, inhibiting tumor progression and preventing the spreading of cancer in patients.
Contacts

Contact Email

Phone number

Social url

Similar Companies
999
TransGenex Nanobiotech

TransGenex Nanobiotech

Florida's TransGenex Nanobiotech develops nano-scale tech for cancer and inflammatory diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care

Location

Tampa, FL, USA

total rounds

1
Elucida Oncology

Elucida Oncology

Elucida Oncology™ develops precision cancer therapeutics using engineering technology.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Monmouth Junction, South Brunswick Township, NJ 08852, USA

total rounds

3

total raised

$94.94M
Ovensa

Ovensa

Ovensa delivers advanced nanotherapeutics through nanomedicine technology platforms.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Biotechnology, Health Care, Pharmaceuticals

Location

Aurora, ON, Canada

total rounds

2

total raised

$1.91M
Nanobiotix

Nanobiotix

Nanobiotix is a nanomedicine company developing cancer therapeutics.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Paris, France

total rounds

11

total raised

$358.46M

Financials

Funding Rounds
7
3

Number of Funding Rounds

$7.9M

Money Raised

Their latest funding was raised on 08.05.2018. Their latest round Venture - Series Unknown

Date 
Funding Round 
Investors 
Money Raised 
Lead 
08.05.2018
$3.23M
18.03.2016
$750K
07.01.2015
$250K
Co-Investors

People

Founders
1
Alexander Ljubimova
Alexander Ljubimova

Alexander Ljubimova

Dr. Alexander Ljubimov is the co-founder of Arrogene. He also serves as Director of the Eye Program, Regenerative Medicine Institute, and as Professor of Biomedical Sciences and Neurosurgery at Cedars-Sinai Medical Center. He is also Professor of Medicine at the University of California Los Angeles David Geffen School of Medicine.

current job

Arrogene
Arrogene

organization founded

1

Alexander Ljubimova

Employee Profiles
5

Julia Y. Ljubimova

Dircetor

Alexander Ljubimova

Alexander Ljubimova

Co-Founder

Jeffrey S. Sperber

Chief Financial Officer and Principal Accounting Officer

Eggehard Holler

Co-Founder

Activity

Recent News
0